Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis.
Journal
PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
22
08
2019
accepted:
13
05
2020
entrez:
24
6
2020
pubmed:
24
6
2020
medline:
11
8
2020
Statut:
epublish
Résumé
Polycystic ovary syndrome (PCOS) is a common, complex genetic disorder affecting up to 15% of reproductive-age women worldwide, depending on the diagnostic criteria applied. These diagnostic criteria are based on expert opinion and have been the subject of considerable controversy. The phenotypic variation observed in PCOS is suggestive of an underlying genetic heterogeneity, but a recent meta-analysis of European ancestry PCOS cases found that the genetic architecture of PCOS defined by different diagnostic criteria was generally similar, suggesting that the criteria do not identify biologically distinct disease subtypes. We performed this study to test the hypothesis that there are biologically relevant subtypes of PCOS. Using biochemical and genotype data from a previously published PCOS genome-wide association study (GWAS), we investigated whether there were reproducible phenotypic subtypes of PCOS with subtype-specific genetic associations. Unsupervised hierarchical cluster analysis was performed on quantitative anthropometric, reproductive, and metabolic traits in a genotyped cohort of 893 PCOS cases (median and interquartile range [IQR]: age = 28 [25-32], body mass index [BMI] = 35.4 [28.2-41.5]). The clusters were replicated in an independent, ungenotyped cohort of 263 PCOS cases (median and IQR: age = 28 [24-33], BMI = 35.7 [28.4-42.3]). The clustering revealed 2 distinct PCOS subtypes: a "reproductive" group (21%-23%), characterized by higher luteinizing hormone (LH) and sex hormone binding globulin (SHBG) levels with relatively low BMI and insulin levels, and a "metabolic" group (37%-39%), characterized by higher BMI, glucose, and insulin levels with lower SHBG and LH levels. We performed a GWAS on the genotyped cohort, limiting the cases to either the reproductive or metabolic subtypes. We identified alleles in 4 loci that were associated with the reproductive subtype at genome-wide significance (PRDM2/KAZN, P = 2.2 × 10-10; IQCA1, P = 2.8 × 10-9; BMPR1B/UNC5C, P = 9.7 × 10-9; CDH10, P = 1.2 × 10-8) and one locus that was significantly associated with the metabolic subtype (KCNH7/FIGN, P = 1.0 × 10-8). We developed a predictive model to classify a separate, family-based cohort of 73 women with PCOS (median and IQR: age = 28 [25-33], BMI = 34.3 [27.8-42.3]) and found that the subtypes tended to cluster in families and that carriers of previously reported rare variants in DENND1A, a gene that regulates androgen biosynthesis, were significantly more likely to have the reproductive subtype of PCOS. Limitations of our study were that only PCOS cases of European ancestry diagnosed by National Institutes of Health (NIH) criteria were included, the sample sizes for the subtype GWAS were small, and the GWAS findings were not replicated. In conclusion, we have found reproducible reproductive and metabolic subtypes of PCOS. Furthermore, these subtypes were associated with novel, to our knowledge, susceptibility loci. Our results suggest that these subtypes are biologically relevant because they appear to have distinct genetic architecture. This study demonstrates how phenotypic subtyping can be used to gain additional insights from GWAS data.
Sections du résumé
BACKGROUND
Polycystic ovary syndrome (PCOS) is a common, complex genetic disorder affecting up to 15% of reproductive-age women worldwide, depending on the diagnostic criteria applied. These diagnostic criteria are based on expert opinion and have been the subject of considerable controversy. The phenotypic variation observed in PCOS is suggestive of an underlying genetic heterogeneity, but a recent meta-analysis of European ancestry PCOS cases found that the genetic architecture of PCOS defined by different diagnostic criteria was generally similar, suggesting that the criteria do not identify biologically distinct disease subtypes. We performed this study to test the hypothesis that there are biologically relevant subtypes of PCOS.
METHODS AND FINDINGS
Using biochemical and genotype data from a previously published PCOS genome-wide association study (GWAS), we investigated whether there were reproducible phenotypic subtypes of PCOS with subtype-specific genetic associations. Unsupervised hierarchical cluster analysis was performed on quantitative anthropometric, reproductive, and metabolic traits in a genotyped cohort of 893 PCOS cases (median and interquartile range [IQR]: age = 28 [25-32], body mass index [BMI] = 35.4 [28.2-41.5]). The clusters were replicated in an independent, ungenotyped cohort of 263 PCOS cases (median and IQR: age = 28 [24-33], BMI = 35.7 [28.4-42.3]). The clustering revealed 2 distinct PCOS subtypes: a "reproductive" group (21%-23%), characterized by higher luteinizing hormone (LH) and sex hormone binding globulin (SHBG) levels with relatively low BMI and insulin levels, and a "metabolic" group (37%-39%), characterized by higher BMI, glucose, and insulin levels with lower SHBG and LH levels. We performed a GWAS on the genotyped cohort, limiting the cases to either the reproductive or metabolic subtypes. We identified alleles in 4 loci that were associated with the reproductive subtype at genome-wide significance (PRDM2/KAZN, P = 2.2 × 10-10; IQCA1, P = 2.8 × 10-9; BMPR1B/UNC5C, P = 9.7 × 10-9; CDH10, P = 1.2 × 10-8) and one locus that was significantly associated with the metabolic subtype (KCNH7/FIGN, P = 1.0 × 10-8). We developed a predictive model to classify a separate, family-based cohort of 73 women with PCOS (median and IQR: age = 28 [25-33], BMI = 34.3 [27.8-42.3]) and found that the subtypes tended to cluster in families and that carriers of previously reported rare variants in DENND1A, a gene that regulates androgen biosynthesis, were significantly more likely to have the reproductive subtype of PCOS. Limitations of our study were that only PCOS cases of European ancestry diagnosed by National Institutes of Health (NIH) criteria were included, the sample sizes for the subtype GWAS were small, and the GWAS findings were not replicated.
CONCLUSIONS
In conclusion, we have found reproducible reproductive and metabolic subtypes of PCOS. Furthermore, these subtypes were associated with novel, to our knowledge, susceptibility loci. Our results suggest that these subtypes are biologically relevant because they appear to have distinct genetic architecture. This study demonstrates how phenotypic subtyping can be used to gain additional insights from GWAS data.
Identifiants
pubmed: 32574161
doi: 10.1371/journal.pmed.1003132
pii: PMEDICINE-D-19-03066
pmc: PMC7310679
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1003132Subventions
Organisme : NICHD NIH HHS
ID : P50 HD044405
Pays : United States
Organisme : NICHD NIH HHS
ID : R24 HD102061
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD057223
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK007169
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD085227
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR002388
Pays : United States
Déclaration de conflit d'intérêts
I have read the journal's policy and the authors of this manuscript have the following competing interests: GNN owns equity in RenalytixAI, Inc., and receives financial compensation as a consultant and advisory board member for RenalytixAI. GNN has received operational funding from Goldfinch Bio and consulting fees from BioVie Inc. and GLG consulting in the past three years. GNN is a former member of the advisory board of PulseData and received consulting fees for their services and continues to hold equity interests in PulseData.
Références
Biology (Basel). 2013 Jan 14;2(1):107-41
pubmed: 24832654
PLoS Genet. 2018 Dec 19;14(12):e1007813
pubmed: 30566500
Fertil Steril. 2004 Jan;81(1):19-25
pubmed: 14711538
J Biol Chem. 2009 Oct 30;284(44):30441-52
pubmed: 19690348
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
Nat Genet. 2006 Aug;38(8):904-9
pubmed: 16862161
Mol Cell Endocrinol. 2016 Oct 15;434:25-35
pubmed: 27297658
Nature. 2014 Mar 27;507(7493):462-70
pubmed: 24670764
PLoS Genet. 2015 Jul 15;11(7):e1005355
pubmed: 26176933
Nat Genet. 2011 Jan;43(1):55-9
pubmed: 21151128
J Biol Chem. 1997 Jan 31;272(5):2984-91
pubmed: 9006946
Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7994-9
pubmed: 11416163
Nucleic Acids Res. 2016 Jul 27;44(13):6046-54
pubmed: 27269582
J Endocrinol Invest. 2008 Jan;31(1):35-41
pubmed: 18296903
Nat Genet. 2017 Oct;49(10):1450-1457
pubmed: 28869590
Am J Obstet Gynecol. 1992 Dec;167(6):1807-12
pubmed: 1471702
J Clin Endocrinol Metab. 2016 Mar;101(3):759-68
pubmed: 26908109
PLoS One. 2017 Jan 13;12(1):e0168288
pubmed: 28085891
Lancet. 2014 Mar 22;383(9922):1084-94
pubmed: 24315621
Endocr Rev. 2015 Oct;36(5):487-525
pubmed: 26426951
PLoS One. 2016 Nov 2;11(11):e0165033
pubmed: 27806063
Cell. 2018 Jun 14;173(7):1573-1580
pubmed: 29906445
Arch Gynecol Obstet. 2013 Oct;288(4):905-10
pubmed: 23553200
Endocr Rev. 2004 Feb;25(1):72-101
pubmed: 14769828
Mol Metab. 2020 May;35:100937
pubmed: 32244180
J Clin Endocrinol Metab. 2019 Apr 30;:
pubmed: 31038695
Pediatr Cardiol. 2017 Aug;38(6):1169-1174
pubmed: 28534241
BMC Med Genomics. 2011 Jan 26;4:13
pubmed: 21269473
Nat Commun. 2016 Jan 12;7:10055
pubmed: 26753790
Endocrinology. 2015 Jan;156(1):301-13
pubmed: 25322464
Curr Opin Neurol. 2016 Dec;29(6):727-734
pubmed: 27749396
Nat Genet. 2016 Oct;48(10):1284-1287
pubmed: 27571263
Arch Gynecol Obstet. 2014 Aug;290(2):315-9
pubmed: 24643802
Fertil Steril. 2014 May;101(5):1404-10
pubmed: 24534286
J Endocr Soc. 2019 Jun 14;3(8):1545-1573
pubmed: 31384717
J Biol Chem. 1998 Oct 2;273(40):26026-35
pubmed: 9748281
Cell Mol Life Sci. 2007 Mar;64(6):768-80
pubmed: 17322986
Hum Reprod. 2004 Jan;19(1):41-7
pubmed: 14688154
J Clin Endocrinol Metab. 2017 Oct 1;102(10):3848-3857
pubmed: 28938447
FEBS J. 2013 Feb;280(3):794-816
pubmed: 23190452
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):E1519-27
pubmed: 24706793
Hum Reprod. 2015 Apr;30(4):937-46
pubmed: 25662806
Nucleic Acids Res. 2005 Jan 1;33(Database issue):D501-4
pubmed: 15608248
Nat Genet. 2012 Sep;44(9):1020-5
pubmed: 22885925
Nucleic Acids Res. 2018 Jan 4;46(D1):D52-D57
pubmed: 29106613
PLoS Genet. 2014 Apr 17;10(4):e1004234
pubmed: 24743097
Nat Commun. 2015 Sep 29;6:8464
pubmed: 26416764
J Clin Endocrinol Metab. 2014 Oct;99(10):E2107-16
pubmed: 24960542
Nucleic Acids Res. 2016 Apr 20;44(7):e70
pubmed: 26704975
Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):18026-31
pubmed: 22003128
Epidemiology. 2008 Sep;19(5):649-51; discussion 657-8
pubmed: 18703928
Diabetes Metab J. 2011 Apr;35(2):91-100
pubmed: 21738890
Cell. 2017 Jun 15;169(7):1177-1186
pubmed: 28622505
Endocr Rev. 2012 Dec;33(6):981-1030
pubmed: 23065822
Bioinformatics. 2010 Sep 1;26(17):2190-1
pubmed: 20616382
Curr Neurol Neurosci Rep. 2014 Nov;14(11):499
pubmed: 25217249
J Hum Reprod Sci. 2017 Jul-Sep;10(3):154-161
pubmed: 29142442
Mol Cell Biol. 2004 Aug;24(16):7032-42
pubmed: 15282304
Diabetes. 2017 Feb;66(2):241-255
pubmed: 27980006
J Womens Health (Larchmt). 2011 Jan;20(1):37-43
pubmed: 21194310
Hum Reprod. 2012 May;27(5):1481-8
pubmed: 22402209
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14956-60
pubmed: 9843997
Neuron. 2014 Feb 5;81(3):484-503
pubmed: 24507187
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
J Neurosci. 1997 Dec 15;17(24):9423-32
pubmed: 9390998
Thorax. 2014 May;69(5):415-22
pubmed: 24563194
PLoS Genet. 2012;8(8):e1002793
pubmed: 22876189
Lancet Diabetes Endocrinol. 2018 May;6(5):361-369
pubmed: 29503172
Fertil Steril. 2014 Jul;102(1):250-256.e3
pubmed: 24825420
J Clin Endocrinol Metab. 2019 Jul 1;104(7):2855-2874
pubmed: 30786001
Circulation. 2017 May 2;135(18):1733-1748
pubmed: 28302752
Am J Hum Genet. 2001 Dec;69(6):1357-69
pubmed: 11593451
Hum Reprod Update. 2009 Jul-Aug;15(4):477-88
pubmed: 19279045
Hum Reprod. 2014 Nov;29(11):2536-43
pubmed: 25267785
Diabetes. 1993 Oct;42(10):1462-8
pubmed: 8375585
Nat Commun. 2015 Aug 18;6:7502
pubmed: 26284813
Biol Reprod. 2010 Dec;83(6):997-1004
pubmed: 20702851
Hum Hered. 2012;74(3-4):118-28
pubmed: 23594490
Nature. 2009 Oct 8;461(7265):747-53
pubmed: 19812666
Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18075-80
pubmed: 15604137
J Clin Endocrinol Metab. 2017 Aug 1;102(8):2862-2872
pubmed: 28505284
Hum Mutat. 2017 Aug;38(8):1025-1032
pubmed: 28493391
Nat Genet. 2007 Jul;39(7):906-13
pubmed: 17572673
Fertil Steril. 2012 Jan;97(1):28-38.e25
pubmed: 22153789
Am J Obstet Gynecol. 2017 May;216(5):493.e1-493.e13
pubmed: 28104402
PLoS Med. 2018 Sep 21;15(9):e1002654
pubmed: 30240442
Reprod Fertil Dev. 2012;24(2):353-61
pubmed: 22281082
N Engl J Med. 2014 Jul 10;371(2):119-29
pubmed: 25006718
Sci Transl Med. 2015 Oct 28;7(311):311ra174
pubmed: 26511511
Mol Endocrinol. 2008 Sep;22(9):2141-61
pubmed: 18599617